TITLE

Endoscopic (oesophageal) ultrasound guided fine needle aspiration (EUS-FNA)

AUTHOR(S)

Richardson, C. M.; Peake, M. D.

PUB. DATE

July 2004

SOURCE

Thorax;Jul2004, Vol. 59 Issue 7, p546

SOURCE TYPE

Academic Journal

DOC. TYPE

editorial

ABSTRACT

The management of lung cancer depends to a great extent on its histological type and the stage of disease. Although most patients with non-small cell lung cancer (NSCLC) have advanced disease at presentation, approximately 30% have tumour confined to the lung and locoregional lymph nodes. In clinical practice a presumptive diagnosis and stage are based on presentation, risk factors, and radiological appearances-particularly CT scans. Obtaining a histological diagnosis and confirming the stage of the disease often take place at the same time. It is reported that mediastinal lymph nodes contain metastatic disease in 28-38% of patients with NSCLC at the time of diagnosis.

ACCESSION #

13997048

 

Related Articles

• Küçük hücreli dışı akciÄŸer karsinomlarında preoperatif metastatik alt mediastinal lenf nodlarının saptanmasının saÄŸkalım üzerinde prognostik etkisi. Keskin, Hakan; Erdoğan, Abdullah; Zeybek, Arife; Dertsiz, Levent; Sarper, Alpay; Demircan, Abid // Journal of Clinical & Experimental Investigations / Klinik ve De;Dec2013, Vol. 4 Issue 4, p453 

  Objective: In our study, we reviewed the survival of patients operated for non-small cell lung cancer (NSCLC) and had positive inferior mediastinal lymph nodes that couldn't be staged with mediastinoscopy prior to surgery in comparison to other mediastinal lymph node involvement, the...

• Worried together: a qualitative study of shared anxiety in patients with metastatic non-small cell lung cancer and their family caregivers. Hendriksen, Ellen; Williams, Emma; Sporn, Nora; Greer, Joseph; DeGrange, Alexandra; Koopman, Cheryl // Supportive Care in Cancer;Apr2015, Vol. 23 Issue 4, p1035 

  Purpose: Anxiety is prevalent, distressing, and understudied among patients with advanced lung cancer and their family caregivers. Preliminary evidence suggests that anxiety is not only present in both patients and caregivers but shared by the dyad. Few studies have examined the nature of shared...

• Frequency of local recurrence following segmentectomy of stage IA non-small cell lung cancer is influenced by segment localisation and width of resection margins — implications for patient selection for segmentectomy Sienel, Wulf; Stremmel, Christian; Kirschbaum, Andreas; Hinterberger, Louisa; Stoelben, Erich; Hasse, Joachim; Passlick, Bernward // European Journal of Cardio-Thoracic Surgery;Mar2007, Vol. 31 Issue 3, p522 

  Abstract: Objective: Segmentectomy has recently been suggested as alternative to lobectomy for curative treatment of early-stage non-small cell lung cancer (NSCLC). This study was performed to investigate if localisation of the resected segment or width of resection margins influence local...

• Phase I clinical and pharmacokinetic study of 3-weekly, 3-h infusion of ixabepilone (BMS-247550), an epothilone B analog, in Japanese patients with refractory solid tumors. Shimizu, Toshio; Yamamoto, Noboru; Yamada, Yasuhide; Fujisaka, Yasuhito; Yamada, Kazuhiko; Fujiwara, Yutaka; Takayama, Kyoko; Tokudome, Takuto; Klimovsky, Judith; Tamura, Tomohide // Cancer Chemotherapy & Pharmacology;Apr2008, Vol. 61 Issue 5, p751 

  Ixabepilone (BMS-247550) is the first in a new class of anti-neoplastic agents, the epothilone analogs, and is a highly active non-taxane anti-microtubule agent. This phase I study aimed to determine the maximum tolerated dose (MTD), dose-limiting toxicities (DLTs), safety profile,...

• Anemia and Limited-stage Small Cell Lung Cancer. Ershler, William B. // Clinical Oncology Alert;Sep2007, Vol. 23 Issue 9, p65 

  There has been much written about the importance and management of anemia in cancer patients this past year. For certain tumors, it is clear that the appearance of anemia prior to therapy confers adverse prognostic implications.1-3 One aspect of the controversy surrounding anemia is whether...

• Cutaneous Metastases of Small-Cell Lung Cancer. Estarriol, Manuel Haro; Goday, Manuel Rubio // New England Journal of Medicine;6/15/2006, Vol. 354 Issue 24, p2583 

  A 70-year-old former smoker presented with a history of several weeks of multiple painless cutaneous nodules on his chest wall. He also reported fatigue, weight loss, and cough with blood-tinged sputum. More than 30 subcutaneous nodules were identified on physical examination. There was no...

• Systemic Chemotherapy for Progression of Brain Metastases in Extensive-Stage Small Cell Lung Cancer. Abdel Karim, Nagla; Bhatt, Ananta; Chiec, Lauren; Curry, Richard // Case Reports in Oncological Medicine;8/28/2015, Vol. 2015, p1 

  Lung cancer is the most common cause of cancer related mortality in men and women. Approximately 15% of lung cancers are small cell type. Chemotherapy and radiation are the mainstay treatments. Currently, the standard chemotherapy regimen includes platinum/etoposide. For extensive small cell...

• Stereotactic body radiation therapy for stage I non-small cell lung cancer: a small academic hospital experience. Witten, Matthew R.; Gittleman, Alicia E.; Catell, Donna T.; Haas, Jonathan A.; Factor, Oren B.; Vu, Charles C.; Schneider, Jeffrey G.; Schubach, Scott L. // Frontiers in Oncology;Oct2014, Vol. 4, p1 

  Purpose/Objective(s): Stereotactic body radiation therapy (SBRT) has been shown to have increased local control and overall survival relative to conventional external beam radiation therapy in patients with medically inoperable stage I non-small cell lung cancer (NSCLC). Excellent rates of local...

• Small cell lung cancer requires complex therapeutic strategies. Mehta, Amit // Hem/Onc Today;9/10/2010, Vol. 11 Issue 17, p8 

  The article discusses the clinical case of a 53-year-old man who was diagnosed with small cell lung cancer.

Read the Article